The Milner Therapeutics Institute are delighted that two of our bio-incubator companies – clock.bio and TRIMTECH Therapeutics – have won Cofinitive #21toWatch awards! The awards spotlight the Top21 standout individuals, game-changing companies, and world-leading innovations from across Cambridge and the East of England.
clock.bio aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells.
TRIMTECH Therapeutics – Neurodegenerative diseases, which include Alzheimer’s and Huntington’s, are caused by protein aggregation inside cells. TRIMTECH’s unique technology targets and degrades aggregated proteins, without affecting non-aggregated forms, offering a solution that is both potent and offers outstanding safety.
Congratulations also to the other winning companies: Bioscopic, BioTryp Therapeutics, Cellestial Health, Evoralis, and Nanomation.
For more information on the #21toWatch awards, visit: cofinitive.com/21towatch-2025-2
